SURGICAL BLISS LIMITEDActive

Company number 12979983Private limited companyIncorporated 2020

Key figures

−£1,338-3,211.6%
Net assets 2024/25
-1.5 k-1 k-50005002020/212021/222022/232023/242024/25

Like most small UK companies, SURGICAL BLISS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k60 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Total assets19,91347,37345,21548,77435,643
Total liabilities19,36846,76244,52148,07136,651
Net assets / total equity5716443-1,338
Average number of employees11221

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company during the year under review was provision of theatre services. The company ceased trading on 30th April 2024.

As described in the company's latest filed accounts.

Summary: SURGICAL BLISS LIMITED

Company

SURGICAL BLISS LIMITED is a private limited company registered with Companies House under company number 12979983. It was incorporated on 28 Oct 2020. Its status is active. The registered office is in Malvern (WR14). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were −£1,338, down 3,211.6% on the previous year. Total assets were £35,643 and total liabilities £36,651. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 10 Nov 2026.